[Treg Cells, and TGF-β Expression and Significance in Chronic Myeloid Leukemia].

Objective: To investigate the expression and significance of regulatory T cells (Tregs), FoxP3 and transforming growth factor-β (TGF-β) in different phase of chronic myeloid leukemia (CML).

Methods: Peripheral blood of 73 CML patients in Department of Hematology, Heze Municipal Hospital from March 2018 to March 2021 were collected. According to patient's period in CML, they were divided into ND CML group (newly diagnosed), CP CML group (chronic period), and BP CML group (blast phase). The percentage of Tregs, expression level of mRNA and TGF-β were detected by flow cytometry, RT-qPCR, and ELISA, respecitively. The roles of above indices in clinical pathogenesis of patients with CML were analyzed.

Results: The proportion of Treg in the ND CML group was slightly higher than the CP CML group, but the difference was not statistically significant ( =0.695), while the BP CML group was significantly higher than the other two groups ( =0.008, <0.001). The expression levels of mRNA in ND CML group, CP CML group and BP CML group were 11.61±2.21, 6.46±1.35 and 8.54±2.13, respectively. Significant difference in mRNA levels was observed among patients in different phases of CML ( =55.199, <0.001). The expression levels of mRNA both in ND CML group and BP CML group were significantly higher than that in CP CML group ( <0.001), and the ND CML group was the highest ( <0.001). However, the expression levels of TGF-β in different phases of CML showed no statistical differences ( =0.634, =0.728).

Conclusion: The abnormal distribution of Treg subset in different phases of CML and the significant increase of the expression level of mRNA in the new onset and blast phase of CML suggest that Tregs may promote the occurrence and progression of CML through immune regulation.